Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura

Internal Medicine

Volumn 50, Issue 12, 2011, Pages 1339-1343

  Takeuchi, Makoto ^a   Yoshida, Chikamasa ^a   Ota, Yusuke ^a   Fujiwara, Yutaka ^a  

^a Department of Internal Medicine   (Japan)

Author keywords

Deep skin infection; Idiopathic thrombocytopenic purpura; Scedosporium apiospermum; Steroid; Voriconazole

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DANAZOL; DOXORUBICIN; IMMUNOGLOBULIN; INSULIN; ITRACONAZOLE; PREDNISOLONE; RITUXIMAB; STEROID; VINCRISTINE; VORICONAZOLE;

ABSCESS DRAINAGE; ADULT; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG CHOICE; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LARGE CELL LYMPHOMA; LIVER INJURY; LOADING DRUG DOSE; LYMPHANGITIS; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; PSEUDALLESCHERIASIS; SCEDOSPORIUM APIOSPERMUM; SKIN BIOPSY; SKIN DEFECT; SKIN ULCER; SPECIES DIFFERENCE; THROMBOCYTE COUNT;

ANTIFUNGAL AGENTS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHANGITIS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; MYCETOMA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRIMIDINES; SCEDOSPORIUM; TRIAZOLES;

EID: 79959287247     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4890     Document Type: Article

References (28)

1. Tadro TS, Workowski KA, Siegel RJ, et al. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallesheria boydii): an emerging mycosis. Hum Pathol 29: 1266-1272, 1998.
2. Lavigne C, Maillot F, de Muret A, Therizol-Ferly M, Lamisse F, Machet L. Cutaneous infection with Scedosporium apiospermum in apatient treated with corticosteroid. Acta Derm Venereol 79: 402-403, 1999.
3. Uenotsuchi T, Moroi Y, Urabe K, et al. Cutaneous infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol 85: 156-159, 2005.
4. Reimann D, Büssemaker E, Gross P. Successful treatment due to Scedosporium apiospermum vacuum seal technique of a severe skin infection in a renal transplant recipient. Nephrol Dial Transplant 19: 245-248, 2004.
5. Raj R, Frost AE. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 121: 1714-1716, 2002.
6. Ochiai N, Shimazaki C, Uchida R, et al. Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia. Leuk Lymphoma 44: 369-372, 2003.
7. Acharya A, Ghimire A, Khanal B, Bhattacharya S, Kumari N, Kanungo R. Brain abscess due to Scedosporium apiospermum in a non immunocompromised child. Indian J Medical Microbiology 24: 231-232, 2006.
8. Shanker S, Biswas J, Gopel L, Bagyalakshmi R, Therese L, Borse NJ. Anterior chamber exudative mass due to Scedosporium apiospermum in an immunocompetent individual. Indian J Medical Microbiology 55: 226-227, 2007.
9. Heath CH, Slavin MA, Sorrell TC, et al. Australian Scedosporium Study Group. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 15: 689-693, 2009.
10. Husain S, Munoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characertistics and impact of antifungal agent therapy on outcome. Clin Infect Dis 40: 89-99, 2005.
11. Caira M, Girmenia C, Valentini CG, et al. Scedosporiosis in a patient with acute leukemia: retrospective muticenter report. Haematologica 93: 104-110, 2008.
12. Travis LB, Roberts GD, Willson WR. Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin Proc 60: 531-537, 1985.
13. Shinohara MM, George E. Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes. J Cutan Pathol 36 (Suppl1): 39-41, 2009.
14. Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA. Pathology of hyalohyphomycosis caused by cedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 29: 1179-1180, 1998.
15. Cunenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 43: 149-151, 1999.
16. Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob. Chemother 49 (suppl 1): 7-10, 2002.
17. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazol, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 39: 954-958, 2001.
18. Barbaric D, Shaw PJ. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole. Med Pediatr Oncol 37: 122-125, 2001.
19. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36: 630-637, 2003.
20. Kappe R. Antifungal activity of the new azole UK-109,496 (voriconazole). Mycoses 42: 83-86, 1999.
21. Bosma F, Voss A, van Hamersvelt HW, et al. Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole. Clin Microbiol Infect 9: 750-753, 2003.
22. Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconzole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 36: 1436-1438, 1998.
23. Munoz P, Marin M, Tornero P, Marine Rabadan P, Rodriguez-Creixems M, Bouza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 31: 1499-1501, 2000.
24. Nesky MA, McDougal EC, Peacock JE Jr. Pseudoallesheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudoallescheriasis. Clin Infect Dis 31: 673-677, 2000.
25. Rogasi PG, Zanazzi M, Nocentini J, et al. Disseminated Scedosporium apiospermum infection in renal transplant recipient: longterm successful treatment with voriconazole: a case report. Transplant Proc 39: 2033-2035, 2007.
26. Walsh TJ, Lutstar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedesporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21: 240-248, 2002.
27. Klopfenstein K, Rosselet JR, Turmuhlen A, Powell D. Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation. Med Pediatr Oncol 41: 494-495, 2003.
28. Troke P, Aguirrebengoa K, Arteaga C, et al. Grobal Scedosporium Study Group. Treatment of Scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 52: 1743-1750, 2008.